CIAM
PLSE icon

Caitong International Asset Management’s Pulse Biosciences PLSE Stock Holding History

Caitong International Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$998 Sell
36
-17
-32% -$401 ﹤0.01% 1549
2026
Q1 		$1.14K Buy
+53
New +$978 ﹤0.01% 1389

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Caitong International Asset Management's PLSE Position: Q2 2026 in Review

Caitong International Asset Management reduced its Pulse Biosciences (PLSE) stake by 32% in Q2 2026, selling an estimated $401 and leaving 36 shares worth $998. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Caitong International Asset Management first reported a position in PLSE in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.14K in Q1 2026. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Caitong International Asset Management held 36 shares of Pulse Biosciences worth $998 as of Q2 2026.
  • Caitong International Asset Management sold 17 Pulse Biosciences shares in Q2 2026, an estimated $401.
  • Pulse Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1549 holding.
  • Caitong International Asset Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Caitong International Asset Management's Pulse Biosciences position peaked at $1.14K in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.